Lilly breaks ground on $6.5bn Houston manufacturing site
Eli Lilly has broken ground on a $6.5bn pharmaceutical manufacturing facility in Houston, Texas, as part of the company’s drive to expand domestic production of medicines and active pharmaceutical ingredients (API). The Houston site is one of 10 US …